Position in EXEL
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$443,822
+$58,627 QoQ
Shares Held
8,157
-9.2% QoQ
Ownership
0.003%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#446
of 751 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in EXEL Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026SHELTON CAPITAL MANAGEMENT holds $30,019,192 across 14 Biotechnology names. EXEL ranks #6 (1.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
29,423 | $14,615,286 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
11,459 | $7,145,144 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
14,556 | $4,381,792 | |
| 4 | ROIV |
Roivant Sciences Ltd.
|
14,598 | $516,623 | |
| 5 | JAZZ |
Jazz Pharmaceuticals plc
|
1,967 | $473,987 | |
| 6 | EXEL |
Exelixis, Inc.
This page
|
8,157 | $443,822 | |
| 7 | PRTA |
Prothena Corp Public Ltd Co
|
39,472 | $386,430 | |
| 8 | ARWR |
Arrowhead Pharmaceuticals, Inc.
|
4,460 | $363,534 |
All Filings in EXEL
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $443,822 | 8,157 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $385,195 | 8,981 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $393,637 | 8,981 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $399,453 | 9,672 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $441,990 | 10,027 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $378,614 | 10,255 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $358,507 | 10,766 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $303,225 | 11,685 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $262,561 | 11,685 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $318,266 | 13,412 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $321,753 | 13,412 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $333,103 | 15,245 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $305,320 | 15,977 | Shares | Sole | 2023-08-10 | |
| 2023-03-31 | $324,088 | 16,697 | Shares | Sole | 2023-05-11 | |
| 2022-12-31 | $267,819 | 16,697 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $261,808 | 16,697 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $347,631 | 16,697 | Shares | Sole | 2022-08-11 | |
| 2022-03-31 | $378,520 | 16,697 | Shares | Sole | 2022-05-12 | |
| 2021-12-31 | $305,221 | 16,697 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 | $374,262 | 17,704 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $322,566 | 17,704 | Shares | Sole | 2021-08-12 | |
| 2021-03-31 | $399,933 | 17,704 | Shares | Sole | 2021-05-14 | |
| 2020-12-31 | $355,319 | 17,704 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $432,862 | 17,704 | Shares | Sole | 2020-11-09 | |
| 2020-06-30 | $420,292 | 17,704 | Shares | Sole | 2020-08-12 | |
| 2020-03-31 | $332,414 | 19,304 | Shares | Sole | 2020-05-13 | |
| No filing history on record for this holder in this stock. | ||||||